Hi [[ session.user.profile.firstName ]]

Identifying and Correcting Common Cell Growth Problems

Introduction - Common cell growth problems and fundamentals of healthy cell cultures: 1:42 - 13:17
Problems related to technique: 13:18 - 19:44
Problems related to media: 19:45 - 26:39
Problems related to cell culture incubators: 26:40 - 33:43
Guide for troubleshooting - general tips and tricks: 33:44 - 38:08
Q&A Session: 38:08 - 47:54

Cell Culture is a powerful research tool in the life sciences. However, the dynamic nature of living cells can make cell culture a difficult tool to work with in the laboratory, even for the most experience hands. As one of the major suppliers of vessels, media, and sera used in cell culture, Corning Life Sciences often receives calls from anxious customers who are experiencing growth or attachment problems with their cell lines to determine what is responsible for the erratic behavior or loss of their cultures. Identifying the underlying causes of erratic cell behavior, unexplained experimental results, or loss of cultures is often a difficult, time-consuming task. This webinar will help identify and solve common cell culture problems can be traced to the three common problem areas of technique, incubators, and media.

Dr. Ann E. Rossi graduated from the University of Rochester School of Medicine and Dentistry with a Ph.D. in Pharmacology and received postdoctoral training at the University of Chicago. Ann began her career with Corning Life Sciences as the Applications Lab Manager where she utilized her strong academic and industry research experience to direct the activities of the Applications Laboratory. Currently, Dr. Rossi is the Senior Bioprocess Applications Scientist, functioning as the technical lead for generating applications in support of Corning Life Sciences’ Bioprocess and Cell/Gene Therapy portfolios including CellCube and HYPERStack platforms.
Recorded Jun 16 2020 48 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Dr. Ann E. Rossi
Presentation preview: Identifying and Correcting Common Cell Growth Problems

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
  • Choosing the Right Cell Culture Surface: Modified Surfaces Oct 28 2021 4:00 pm UTC 60 mins
    Ann Rossi Bilodeau, PhD, Corning Life Sciences
    Choosing the right cell culture surface can be a challenge, especially with a diverse range of options extending beyond traditional tissue culture-treated polystyrene. Ultimately, the cell culture surface mimics cells’ native environments and drives cell morphology, phenotype, and function. Consequently, the choice of cultureware is critical for successful cell growth.

    In this webinar you will learn:
    • A brief history of the evolution of cell culture surfaces
    • The difference between surface modifications and coating
    • Basic principles behind tissue culture treatment
    • When to use enhanced attachment surfaces
  • 3D Cell Culture Techniques; For Spheroid and Organoid Applications Oct 28 2021 5:00 am UTC 60 mins
    Meng-Tsz Tsai
    3D cell culture is gaining traction in basic research and medicine discovery due to the more physiologically relevant characteristics than traditional (2D) cell culture. Corning has delivered pioneer tools that have advanced the science of 3D cell culture within the past decades. In this webinar we will introduce 3D cell culture techniques, applications, and culture tips and tricks that will help you to get started on the path to 3D cell culture.
  • Understanding Cell Culture Media Oct 21 2021 4:00 pm UTC 60 mins
    Sherwin (Xiaoyu) Zhu, PhD
    This webinar will introduce the primary characteristics of basal media and will provide tips and best practices to select correct basal media and optimize cell culture. In addition, you will learn:

    • Considerations to select correct media formulation
    • Key factors that affect media performance

    Dr. Xiaoyu Zhu is a Scientific Support Specialist for North America at Corning Life Sciences. He received a Ph.D. in Cell Biology at Beijing Normal University. Dr. Zhu was an Associate Professor at the Chinese Center for Disease Control and Prevention (China CDC). In his current role, he supports customers with product selection, application support, and troubleshooting. He has been with Corning for eight years.
  • Biomaster & Corning 共同セミナー Oct 19 2021 6:00 am UTC 60 mins
    コーニングインターナショナル 石渡 孝至 / バイオマスター 吉田 進也


    ※本セミナーお申込みの際に入力いただきました個人情報は、コーニングインターナショナル株式会社と株式会社バイオマスターとで共有させていただきます。またその情報は、質問の回答およびCORNING NEWS などのお知らせメールの配信を含む弊社の営業・マーケテイング活動に使用させていただきます。
  • Cultivo celular en 3D Recorded: Oct 14 2021 58 mins
    Gisela Pennacchio, pHD
    Principales Aspectos del Cultivo 3D
    Ventajas y Herramientas para su Uso
    Tecnicas de Generacion de Esferoides
    Caracterizacion de Esferoides
  • Male Sex Hormones Increase Excitatory Neuron Production in HCO Recorded: Oct 12 2021 26 mins
    Iva Kelava, Ph.D., Postdoctoral Fellow, MRC Laboratory of Molecular Biology
    Title: Male Sex Hormones Increase Excitatory Neuron Production in Human Cerebral Organoids


    Bioengineered tissue platforms offer a new paradigm for modeling human pathophysiology and testing drug efficacy and safety. To model whole-body physiology and systemic diseases, we developed the biomimetic InterOrgan platform in which matured human tissues are connected in a way that allows maintaining distinct functionalities of different organs. Each tissue is cultured in its own optimized environment and integrated via recirculating vascular flow containing monocytes, by a matured and selectively permeable endothelial barrier. Tissues linked by vascular perfusion maintained their molecular, structural, and functional phenotypes over four weeks of culture, recapitulate multi-organ toxicity of doxorubicin and clinically relevant miRNA biomarkers, and show utility for immune-oncology applications.
  • Upstream Viral Vector Manufacturing: Transfections of Adherent Cultures at Scale Recorded: Oct 7 2021 44 mins
    Cassie-Marie Peigné, PhD, Polyplus-transfection® and Ann Rossi Bilodeau, PhD, Corning Life Sciences
    Many cell and gene therapy applications are dependent on viral vectors for recombinant gene delivery. Efficient transfection of a large biomass of cells represents a significant challenge for transient viral vector production systems. However, identifying a scalable adherent cell culture platform for high density cell culture and relying on a transfection reagent that can ensure robust and reproducible viral yields at scale are essential to streamline transition from process development to manufacturing.

    Introduction: 1:36 – 7:57
    – Viral vector use in cell and gene therapy applications
    – Challenges for vector production
    Considerations for Choosing a Cell Culture Platform: 7:58 – 14:43
    – Adherent versus suspension
    – Typical upstream scale-up/scale-out
    Bottlenecks to Scalable Transfections: 14:44 – 30:40
    – Science behind Polyplus® reagents, featuring PEIpro®
    – Protocol review for Corning® CellSTACK® and CellCube® vessels
    Q&A Session: 30:41 – 43:09
  • Engineering Integrated Multi-Tissue Platforms for Modeling Human Pathologies Recorded: Sep 20 2021 30 mins
    Kacey Ronaldson Bouchard, Ph.D., Associate Research Scientist, Columbia University
    Title: Engineering Integrated Multi-Tissue Platforms for Modeling Systemic Human Pathologies


    Bioengineered tissue platforms offer a new paradigm for modeling human pathophysiology and testing drug efficacy and safety. To model whole-body physiology and systemic diseases, we developed the biomimetic InterOrgan platform in which matured human tissues are connected in a way that allows maintaining distinct functionalities of different organs. Each tissue is cultured in its own optimized environment and integrated via recirculating vascular flow containing monocytes, by a matured and selectively permeable endothelial barrier. Tissues linked by vascular perfusion maintained their molecular, structural, and functional phenotypes over four weeks of culture, recapitulate multi-organ toxicity of doxorubicin and clinically relevant miRNA biomarkers, and show utility for immune-oncology applications.
  • Yamaha Motor & Corning 共同セミナー Recorded: Sep 15 2021 61 mins
    コーニング 江藤 哉子 / ヤマハ発動機 原田 額郎 Ph.D.
    オルガノイドやスフェロイドを形成するために広く用いられる、コーニングの超低接着表面及びCorning® マトリゲル基底膜マトリックスとその培養手法をご紹介いたします。

    細胞ピッキング&イメージングシステムCELL HANDLER™ の基本機能と活用例
    CELL HANDLERは、シングルセルから3D細胞まで幅広い細胞を対象としたイメージベースの細胞ピッキング装置です。独自のピッキング技術は、ダメージレスに目的細胞を分取し、人手では困難であったゲル包埋オルガノイドや2D接着細胞の単離も実現します。これにより、実験効率や再現性、トレーサビリティを向上し、幹細胞研究やがん研究分野の発展に貢献します。

    またその情報は、質問の回答およびCORNING NEWS などのお知らせメールの配信を含む弊社の営業・マーケテイング活動に使用させていただきます。
  • 코닝의 3D spheroid와 organoid 배양 관련 제품과 사용 예시 Recorded: Aug 13 2021 53 mins
    Seo Kyubin (Andrew)
    3D 세포 배양에 대한 연구는 여전히 활발하게 진행되고 있으며, 이에 대한 관심과 수요가 지속적으로 증가하고 있는 상황입니다.
    많은 3D 세포 배양 방법 중에서도 스페로이드 & 오가노이드 배양과 관련된 코닝의 제품을 소개하고, 관련 예와 실험적인 팁을 설명합니다.
    Airway 오가노이드에 대한 배양법과 관련 제품들을 소개하며, COVID-19 virus에 대한 오가노이드 model로 어떻게 사용될 수 있는지 설명합니다.
  • Olympus & Corning共同セミナー Recorded: Jul 20 2021 46 mins
    コーニングインターナショナル株式会社 石渡 孝至 / オリンパス株式会社 横町 祐樹

    インキュベーションモニタリングシステム CM20は、インキュベーター内で培養中の細胞数や密度を自動で計測します。培養従事者がクリーンルームに入ることなく培養状況を確認でき、これまで計測に費やしていた時間やコストが大幅に削減されます。大型容器や多層フラスコまでのスケールアッププロセスにおいても一貫したデータ計測が可能なため、スケールアップのプロセス開発にも大いに貢献します。

    ※本セミナーお申込みの際に入力いただきました個人情報は、コーニングインターナショナル株式会社とオリンパス株式会社とで共有させていただきます。またその情報は、質問の回答およびCORNING NEWS などのお知らせメールの配信を含む弊社の営業・マーケテイング活動に使用させていただきます。
  • Challenges and Processes for Development and Scale-up of Stem Cell Therapies Recorded: Jul 16 2021 62 mins
    Carolyn Wrightson, Ph.D., VetStem Biopharma and Austin Mogen, Ph.D., Corning Incorporated
    GMP cell manufacturing for new clinical cell therapies is a rapidly expanding need in the life science space. This presentation will discuss the foundation of cell therapy product development considerations when preparing to launch into manufacture of materials in support of early Phase clinical trials to commercialization. Historical development of an autologous canine mesenchymal stem-cell product that facilitated the ability to rapidly respond to develop and manufacture an allogeneic human MSC product for treatment of COVID-19 patients with ARDS will be presented.
    Learning Objectives:
    - MSC isolation from tissue to success in primary cell culture
    - Characterization of cell lines
    - Avoiding development pitfalls in the scale-up of cell therapy manufacturing

    Carolyn Wrightson, Ph.D.
    Chief of Operations
    VetStem Biopharma

    Austin Mogen, Ph.D.
    Senior Field Application Scientist
    Corning Incorporated | Life Science
  • Corning® CellBIND: Reducing Serum Levels and Culture Costs (Vietnamese Version) Recorded: Jul 13 2021 35 mins
    Dzung Do Van
    A major cost component of cell culture is fetal bovine serum (FBS), an often essential and very expensive. Many researchers routinely use media containing 10 to 20% FBS for growing the cells, but these levels may be higher than cells require. By reducing FBS levels by 50%, researchers may be able to save a considerable amount of money. Not all cell lines will do well at lower FBS levels although many will. This short presentation will help you better understand the steps you can take to reduce your cultures’ FBS levels and save money while keeping your cultures happy.
  • コーニングの3D細胞培養関連製品と使用例 Recorded: Jun 29 2021 53 mins
    コーニングインターナショナル株式会社 ライフサイエンス事業部 江藤 哉子
    ますます需要の高まる3D細胞培養について、その概要とコーニングの各種関連製品を、使用例を含めながらご説明します。また6月1日発売の新製品Corning® 3D組織透明化試薬もご紹介します。

    ※下記URLのコーニングのプライバシーポリシーにご同意のうえご登録ください。ご登録いただいたお名前、ご所属、電子メールアドレス、電話番号、その他の情報は、質問の回答およびCorning Newsなどのお知らせメールの配信を含む弊社の営業・マーケテイング活動に使用させていただきます。
  • 3D Human Liver Spheroids: Moving Towards Meaningful In Vitro Assays Recorded: Jun 9 2021 39 mins
    Michael Johnson, Ph.D., CEO, Visikol, Inc. and Feng Li, Ph.D., Development Associate Corning Life Sciences
    Human liver spheroids are being utilized as a novel in vitro tool for drug safety assessment and liver disease modeling. Corning® HepGo™ Assay-ready 3D Liver Spheroid Kit featuring pre-qualified primary human hepatocytes has been developed to provide researchers an easy access to the more physiologically relevant tool. In this tutorial, we will share our experiences to facilitate a conversation on how to use liver spheroids for in vitro assays.
  • Disease Modeling Using ALI Tools and Systems Recorded: Jun 4 2021 12 mins
    Roxana Ghadessy, Ph.D. and Shabana Islam, Ph.D.- Corning Life Sciences
    From asthma to COPD, ALI models have been critical in researching respiratory diseases. With the recent outbreak and severity of the SARS-CoV-2 virus, this technology is becoming even more critical in the race to understand and treat disease.

    With the popularity of these more complex models growing, join this Teach Me in 10 session to hear Corning Life Sciences Digital Manager Roxana Ghadessy and Corning Life Sciences Product Line Manager Shabana Islam talk to us about disease modeling using ALI tools and systems.
  • Corning Solutions for Cell Therapy Bioprocessing Recorded: May 27 2021 48 mins
    Franco So
    This webinar illustrates the Corning cell isolation and expansion platforms to meet scale-up and other challenges in cell therapy bioprocessing.
    Corning’s recent investments into providing automation around Stackable Vessels operations as well as in optical based cell isolation technologies would decrease lot-to-lot variability for manufacturing.
    For larger-scale applications, Corning’s focus into microcarrier-based technologies accelerates allogenic large-scale production of stem cells.
    Fixed bed platforms such as CellCUBE can also support adherent-based perfusion cultures which would be applicable for exosome-based therapies.
  • 多細胞系からなるiPS細胞由来ヒト肝臓オルガノイドを用いた脂肪性肝炎モデリング Recorded: May 21 2021 31 mins
    東京医科歯科大学 統合研究機構 先端医歯工学創成研究部門 創生医学コンソーシアム臓器発生・創生ユニット 特任研究員 大内 梨江先生
  • Pipetting Techniques and Avoiding Contamination Recorded: May 4 2021 37 mins
    Julie Kalungi, Scientific Support Specialist at Corning Life Sciences
    While often taken for granted, proper techniques for pipetting and pipettor handling are both very important when performing liquid handling measurements. Using proper technique is imperative for avoiding cross-contamination that can ruin the sample and affect the entire research process. By attending this webinar, you will learn about:

    - Good pipetting practices: 2:41 - 5:54
    - Proper pipetting techniques: 5:55 - 23:14
    - Avoiding contamination: 23:15 - 29:24
    - Key takeaways: 29:25 - 30:12
    - Q&A: 30:13 - 36:16
  • Advanced Trends and Tools for Gene Therapy Recorded: Apr 29 2021 38 mins
    Constanza Curotto
    This webinar is part of Bioprocess Webinar Series. See other webinars in this series on our webinar page - Advanced Trends and Tools for Immune Cell Therapy and Advanced Trends and Tools for Stem Cell Therapy.

    Once considered conceptual, gene therapy has now become a reality, and as this therapy becomes more widely adopted, the need for larger batch sizes will ultimately conflict with the amount of available space in clean rooms. Building on a long and expert history in cell culture, Corning offers viral vector manufacturing platforms that are easily integrated into modular production set-ups, such as Corning® HYPERStack® and CellSTACK® vessels, which are enabling viral vectors to be produced at large scales. This seminar will introduce you to the new tools and solutions that Corning has developed for this field, as well as applications related to viral vector production.

    Presenter bio:
    After graduating from Biochemistry from the University of Santiago (Chile), Constanza perused a career in the Chilean animal health industry, developing as a Bioprocess Scientist for vaccine production in charge of scale-up and tech transfer. She furthered developed her career in Belgium, in the field of antibody production in suspension cell lines. Constanza is currently a Field Application Scientist for the EMEA region, providing customers in-depth technical support, presenting seminars and trainings, and assisting customers in experimental set-up and troubleshooting.
Training for Life Science Researchers
The Corning Scientific Seminar Series is a series of free, online technical presentations that provide novel tips, best practices and proven techniques to help advance your research. Delivered by scientists to scientists, these one-hour broadcasts offer useful information and tips for lab technicians and researchers.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Identifying and Correcting Common Cell Growth Problems
  • Live at: Jun 16 2020 3:00 pm
  • Presented by: Dr. Ann E. Rossi
  • From:
Your email has been sent.
or close